PapersPMID:38398813
Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial.
What moved
1 findingHow to read these marks →“Following six weeks of supplementation with Levagen+® PEA, the expression of serum BDNF significantly increased by 2.76 ± 6.12 ng/mL (p = 0.0005) compared with no change in the placebo (−0.72 ± 7.16 ng/mL; p = 0.39).”
- Study
- crossover
- Participants
- 39
- Duration
- 6 weeks
- Interests
- Industry funded
- Dose studied
- Levagen+ (formulated PEA), 2 capsules daily, 600 mg PEA total daily dose, oral, 6 weeks
- Population
- Healthy young university students in London, randomised double-blind placebo-controlled crossover, 6-week arms with 6-week washout; placebo was microcrystalline cellulose capsules
Study record
- Design
- crossover trial
- Species
- human
- Population
- Healthy full-time university students in London, aged 18 years and above
- Participants
- 39
- Comparator
- placebo
- Duration
- 42 days
- Endpoints measured
- 16